NASDAQ:ALGS | Cash Flow Statement | Aligos Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2019-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$1.5M
2026-03-31-$23.04M-$23.13M$34.93M-$62,000.00
2025-12-31-$19.88M-$21.75M-$2.02M$123,000.00
2025-09-30-$31.54M
2025-06-30-$15.86M
2025-03-31$43.09M-$20.91M-$44.07M$101.74M
2024-12-31-$82.15M-$18.4M$19.97M$97,000.00
2024-09-30-$19.26M
2024-06-30$5.06M
2024-03-31-$34.86M-$22.75M-$88.64M-$19,000.00
2023-12-31-$27.89M-$22.66M-$7,000.00$87.94M
2023-09-30-$18.04M
2023-06-30-$18.79M
2023-03-31-$22.96M-$22.39M$7,000.00$19.99M-$1,000.00
2022-12-31-$21.89M-$16.78M$91,000.00$11.6M$121,000.00
2022-09-30-$18.62M
2022-06-30-$19.92M
2022-03-31-$35.62M-$20.43M$515,000.00-$60.4M-$21,000.00
2021-12-31-$37.71M-$37.48M$336,000.00-$16.48M$552,000.00
2021-09-30-$33.12M
2021-06-30-$29.82M
2021-03-31-$27.67M-$29.8M$307,000.00$9.69M$78,000.00
2020-12-31-$34.42M-$19.68M$61,000.00$14.94M$193.32M
2020-09-30-$33.3M
2020-06-30-$20.8M
2020-03-31-$20.03M-$20.32M$1.09M-$23.77M-$48,000.00
2019-12-31-$18.18M-$15.02M$721,000.00-$21.81M$85.26M
2019-09-30-$14.05M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$24.19M-$82.5M-$37.83M$101.64M
2024-12-31-$131.21M-$80.74M$130,000.00-$18.28M$355,000.00
2023-12-31-$87.68M-$79M$19,000.00$44.98M$88.33M
2022-12-31-$96.05M-$79.39M$943,000.00-$26.29M$164,000.00
2021-12-31-$128.33M-$115.66M$892,000.00$3.02M$78.68M
2020-12-31-$108.54M-$74.26M$2.06M$32.76M$192.35M
2019-12-31-$52.26M-$46.77M$2.79M$6.79M$85.53M